110 related articles for article (PubMed ID: 9368662)
1. Characteristics of rhabdomyosarcoma cell lines derived from uterine carcinosarcomas.
Emoto M; Iwasaki H; Oshima K; Kikuchi M; Kaneko Y; Kawarabayashi T
Virchows Arch; 1997 Oct; 431(4):249-56. PubMed ID: 9368662
[TBL] [Abstract][Full Text] [Related]
2. Two cell lines established from mixed müllerian tumors of the uterus. Morphologic, immunocytochemical, and cytogenetic analyses.
Emoto M; Iwasaki H; Kikuchi M; Ishiguro M; Kubota T; Izumi H; Shirakawa K; Kaneko Y
Cancer; 1992 Apr; 69(7):1759-68. PubMed ID: 1312893
[TBL] [Abstract][Full Text] [Related]
3. Characteristics of cloned cells of mixed müllerian tumor of the human uterus. Carcinoma cells showing myogenic differentiation in vitro.
Emoto M; Iwasaki H; Kikuchi M; Shirakawa K
Cancer; 1993 May; 71(10):3065-75. PubMed ID: 7683967
[TBL] [Abstract][Full Text] [Related]
4. Tissue polypeptide antigen production in a uterine carcinosarcoma cell line in a serum-free culture.
Emoto M; Iwasaki H; Kikuchi M; Shirakawa K
Gynecol Oncol; 1996 Mar; 60(3):443-9. PubMed ID: 8774655
[TBL] [Abstract][Full Text] [Related]
5. Establishment and characterization of a serous papillary adenocarcinoma cell line of the human ovary in a serum-free culture.
Emoto M; Oshima K; Ishiguro M; Iwasaki H; Kawarabayashi T; Kikuchi M
Pathol Res Pract; 1999; 195(4):237-42. PubMed ID: 10337661
[TBL] [Abstract][Full Text] [Related]
6. TNP-470 inhibits growth and the production of vascular endothelial growth factor of uterine carcinosarcoma cells in vitro.
Emoto M; Ishiguro M; Iwasaki H; Kikuchi M; Kawarabayashi T
Anticancer Res; 2000; 20(1C):601-4. PubMed ID: 10769702
[TBL] [Abstract][Full Text] [Related]
7. Carcinosarcomas (malignant mixed Müllerian tumor) of the uterus: advances in elucidation of biologic and clinical characteristics.
Kernochan LE; Garcia RL
J Natl Compr Canc Netw; 2009 May; 7(5):550-6; quiz 557. PubMed ID: 19460280
[TBL] [Abstract][Full Text] [Related]
8. CD133+ cancer stem cell-like cells derived from uterine carcinosarcoma (malignant mixed Müllerian tumor).
Choijamts B; Jimi S; Kondo T; Naganuma Y; Matsumoto T; Kuroki M; Iwasaki H; Emoto M
Stem Cells; 2011 Oct; 29(10):1485-95. PubMed ID: 21919130
[TBL] [Abstract][Full Text] [Related]
9. CD34 immunohistochemistry in female genital tract carcinosarcoma (malignant mixed müllerian tumors) supports a dominant role of the carcinomatous component.
Costa MJ; Guinee D
Appl Immunohistochem Mol Morphol; 2000 Dec; 8(4):293-9. PubMed ID: 11127921
[TBL] [Abstract][Full Text] [Related]
10. Expression of CD10 in malignant müllerian mixed tumors and adenosarcomas: an immunohistochemical study.
Mikami Y; Hata S; Kiyokawa T; Manabe T
Mod Pathol; 2002 Sep; 15(9):923-30. PubMed ID: 12218209
[TBL] [Abstract][Full Text] [Related]
11. Establishment and characterization of carcinosarcoma cell line of the human uterus.
Gorai I; Doi C; Minaguchi H
Cancer; 1993 Feb; 71(3):775-86. PubMed ID: 8431860
[TBL] [Abstract][Full Text] [Related]
12. Cytogenetic and cellular characteristics of a human embryonal rhabdomyosarcoma cell line, RMS-YM.
Kubo K; Naoe T; Utsumi KR; Ishiguro Y; Ueda K; Shiku H; Yamada K
Br J Cancer; 1991 Jun; 63(6):879-84. PubMed ID: 1906291
[TBL] [Abstract][Full Text] [Related]
13. Genetic characterisation of adult primary pleomorphic uterine rhabdomyosarcoma and comparison with uterine carcinosarcoma.
Ashley CW; Da Cruz Paula A; Ferrando L; Gularte-Mérida R; Sebastiao APM; Brown DN; Gazzo AM; Pareja F; Stylianou A; Abu-Rustum NR; Reis-Filho JS; Buehler D; Weisman P; Chiang S; Weigelt B
Histopathology; 2021 Aug; 79(2):176-186. PubMed ID: 33527450
[TBL] [Abstract][Full Text] [Related]
14. The immunohistochemical profile of malignant mixed müllerian tumor. Overlap with endometrial adenocarcinoma.
Meis JM; Lawrence WD
Am J Clin Pathol; 1990 Jul; 94(1):1-7. PubMed ID: 1694389
[TBL] [Abstract][Full Text] [Related]
15. Effect of angiogenesis inhibitor TNP-470 on the growth, blood flow, and microvessel density in xenografts of human uterine carcinosarcoma in nude mice.
Emoto M; Ishiguro M; Iwasaki H; Kikuchi M; Kawarabayashi T
Gynecol Oncol; 2003 Apr; 89(1):88-94. PubMed ID: 12694659
[TBL] [Abstract][Full Text] [Related]
16. The in vitro growth, heterotransplantation, and differentiation of a human rhabdomyosarcoma cell line.
Garvin AJ; Stanley WS; Bennett DD; Sullivan JL; Sens DA
Am J Pathol; 1986 Oct; 125(1):208-17. PubMed ID: 3777136
[TBL] [Abstract][Full Text] [Related]
17. Characterization of an embryonal rhabdomyosarcoma cell line showing amplification and over-expression of the N-myc oncogene.
Hayashi Y; Sugimoto T; Horii Y; Hosoi H; Inazawa J; Kemshead JT; Inaba T; Hanada R; Yamamoto K; Gown AM
Int J Cancer; 1990 Apr; 45(4):705-11. PubMed ID: 2323848
[TBL] [Abstract][Full Text] [Related]
18. MYCN gene amplification in rhabdomyosarcoma.
Driman D; Thorner PS; Greenberg ML; Chilton-MacNeill S; Squire J
Cancer; 1994 Apr; 73(8):2231-7. PubMed ID: 8156531
[TBL] [Abstract][Full Text] [Related]
19. Concomitant amplification and expression of PAX7-FKHR and MYCN in a human rhabdomyosarcoma cell line carrying a cryptic t(1;13)(p36;q14).
Frascella E; Lenzini E; Schafer BW; Brecevic L; Dorigo E; Toffolatti L; Nanni P; De Giovanni C; Rosolen A
Cancer Genet Cytogenet; 2000 Sep; 121(2):139-45. PubMed ID: 11063797
[TBL] [Abstract][Full Text] [Related]
20. Uterine carcinosarcoma: immunohistochemical studies on tissue microarrays with focus on potential therapeutic targets.
Cimbaluk D; Rotmensch J; Scudiere J; Gown A; Bitterman P
Gynecol Oncol; 2007 Apr; 105(1):138-44. PubMed ID: 17175012
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
